false
OasisLMS
Skip Navigation Links
Publications
JTO
CRR
ILCN
Menu
Publications
JTO
CRR
ILCN
Hamburger Menu
Catalog
2022 North America Conference on Lung Cancer (Slid ...
2022 North America Conference on Lung Cancer (Slides)
Conference | English | 2022
Create Account
Availability
On-Demand
12 Courses
Cost
$0.00
Credit Offered
No Credit Offered
Attendee Access Instructions
Attendee Access: This product is for live/hybrid conference attendees.
Extended Conference Access:
Click here to purchase.
Questions? Contact
education@iaslc.org
.
Summary
The IASLC 2022 NACLC is a dynamic meeting with a long tradition and will feature the most up-to-date research, diverse topics of interest, and educational sessions with leading experts. The Conference is an amazing opportunity to network across disciplines with other individuals in careers focused on thoracic malignancies, while learning about the latest developments in prevention, detection, and care with novel data presentations.
Accreditation Release Dates
Live Activity Dates: September 23-25, 2022
Target Audience
The IASLC World Conference on Lung Cancer is designed to meet the educational needs of researchers and healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists, advanced practice nurses and physician associates.
Learning Objectives
At the conclusion of this activity, participants will be able to:
Apply evidence-based recommendations and clinical practice guidelines to diagnose and treat patients with lung cancer and other thoracic malignancies.
Describe the impact of COVID-19 on lung cancer care, research, and prevention efforts.
Describe scientific advances in lung cancer and other thoracic malignancies.
Synthesize research from clinical trials and translational studies to deepen knowledge within primary specialty area(s) and broaden knowledge of other specialties.
Advocate for lung cancer prevention strategies including tobacco control, smoking cessation, reducing environmental risks, and implementing early screening.
Engage and empower patients to become active participants in their treatment.
Program Co-Chairs
Jessica Donington, MD
Marina Garassino, MD
Jyoti Patel, MD
Disclosure Information
Click here to view the full list of 2022 NACLC Faculty and their Disclosures
Accreditation
Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Association for the Study of Lung Cancer is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statements:
Physicians
The International Association for the Study of Lung Cancer designates the “other activity” (a live conference offered in a hybrid format including recorded virtual participation) format for this educational activity for a maximum
of 16.0
AMA PRA Category 1 Credits
TM
.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurse Practitioners and Registered Nurses
For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education).
Physician Assistants
The National Commission on Certification of Physician Assistants (NCCPA) states that the AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification.
Countries that accept ACCME-accredited continuing medical education (CME):
The below list includes countries that accept ACCME-accredited continuing medical education (CME). Please note that some countries that accept ACCME-accredited education do not have specific credit requirements for their physicians.
Antigua & Barbuda
Regulator:
Antigua & Barbuda Medical Council
Austria
Regulator:
Austrian Academy of Physicians on behalf of the Austrian Medical Chamber
Bahamas
Regulator:
Bahamas Medical Council
Belgium
Regulator:
Group of Belgian Professional Unions of Specialist Doctors
Bhutan
Regulator:
Medical and Health Professional Council, Royal Government of Bhutan
Canada
Regulator:
Royal College of Physicians and Surgeons of Canada Maintenance of Certification Program
Croatia
Regulator:
Croatian Medical Chamber
Gambia, The
Regulator:
The Medical and Dental Council of the Gambia
Germany
Regulator:
State Chambers of Physicians in the 16 federal states
(only in-person, live events)
India, State of Punjab
Regulator:
Punjab Medical Council
Israel
Regulator:
Scientific Council, Israeli Medical Association
Jamaica
Regulator:
Medical Council of Jamaica
Kuwait
Regulator:
Professional Licensing - Ministry of Health
Malawi
Regulator: Medical Council of Malawi
Netherlands, The
Regulator:
Royal Dutch Society of the Promotion of Medicine
Oman
Regulator:
Oman Medical Specialty Board
Qatar
Regulator:
Accreditation Section of the Department of Healthcare Professions of the Qatar Ministry of Public Health
Rwanda
Regulator:
Rwanda Medical & Dental Council
Saudi Arabia
Regulator:
Saudi Commission for Health Specialties
Singapore
Regulator:
Singapore Medical Council
South Africa
Regulator:
Health Professions Council of South Africa
Spain
Regulator:
Spanish Medical Professional Accreditation Council for CPD/CME
Sri Lanka
Regulator:
Sri Lanka Medical Council, Sri Lanka Medical Association, and the Ministry of Health
Sweden
Regulator:
Swedish Medical Association
Trinidad & Tobago
Regulator:
The Trinidad and Tobago Medical Association
Turkey
Regulator:
Turkish Medical Association CME-CPD Accreditation Council
United Arab Emirates, Abu Dhabi
Regulator:
Department of Health
United Arab Emirates, Dubai
Regulator:
Dubai Health Authority
Off Label Disclosure
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of the IASLC or any company that provided commercial support for this activity.
Disclaimer
The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Instructions for Participation and Credit
There is a fee for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; participants should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page.
Follow these steps to earn CME/CE credit*:
Read about the target audience, learning objectives, and author disclosures.
Study the educational content online or print it out, if applicable.
Complete the activity evaluation to provide feedback for future programming and receive credit.
You may now view or print the certificate from your CME/CE Transcript. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Transcript and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Transcript.
*The credit that you receive is based on your membership profile.
Contact Information
If you need assistance with this activity, please email:
education@iaslc.org
.
×
2022 North America Conference on Lung Cancer (Slides) Course List
Lung Cancer Delivery in Unprecendented Times
Cancer Immunotherapy: Targeting Immune Dysfunction in Tumor Sites
The Rapid Evolution of Peri-Operative Immune Therapy in NSCLC
Oral Abstract Session 1
Session 1: Immune Checkpoint Inhibitors - Implications for Cure
Session 2: Medical Oncology - Targeted Therapy (including Resistance, KRAS, HER2, Toxicity, ADC)
Session 3: Local Therapy in NSCLC
Session 4: Implications for Immunotherapy in Subsets of Patients with Thoracic Disease
Session 5: SCLC & Important Updates in Thoracic Oncology - Updates from WCLC
Session 6: Medical Oncology - Translational Science and Immunotherapy
Session 7: Screening, Early Detection and Nodule Management
Women's Forum Networking
Login
User Login
Continue with Google
OR
Email
Required
Password
Required
Logging In…
Create Account
Forgot Password
×
Please select your language
1
English